COVID-19 and SARS-CoV-2: Despite the vaccination, new targets/drugs for treatment and the virus cycle mechanisms still have to be continually investigated
Open Access
- 10 February 2021
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Proteomics and Genomics
- Vol. 6 (1), 001-003
- https://doi.org/10.17352/ojpg.000010
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populationsCell Discovery, 2020
- Parents’ hesitancy towards vaccination in Indonesia: A cross-sectional study in IndonesiaVaccine, 2020
- Evolutionary Medicine of Retroviruses in the Human GenomeThe American Journal of the Medical Sciences, 2019
- The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA TransferCell, 2018
- Contribution of Syncytins and Other Endogenous Retroviral Envelopes to Human Placenta PathologiesPublished by Elsevier BV ,2017
- Pan-vertebrate comparative genomics unmasks retrovirus macroevolutionProceedings of the National Academy of Sciences of the United States of America, 2014
- Endogenous Viral Elements in Animal GenomesPLoS Genetics, 2010
- Endogenous retrovirusesCellular and Molecular Life Sciences, 2008
- Endogenous Retroviruses and Human EvolutionComparative and Functional Genomics, 2002